Related references
Note: Only part of the references are listed.Preventive effect of vitamin D3 supplementation on conversion of optic neuritis to clinically definite multiple sclerosis: a double blind, randomized, placebo-controlled pilot clinical trial
Hajar Derakhshandi et al.
ACTA NEUROLOGICA BELGICA (2013)
Interdependence and contributions of sun exposure and vitamin D to MRI measures in multiple sclerosis
Robert Zivadinov et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
Vitamin D status: Multifactorial contribution of environment, genes and other factors in healthy Australian adults across a latitude gradient
Robyn M. Lucas et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2013)
Pharmacoepidemiology and the Australian regional prevalence of multiple sclerosis
Samantha Hollingworth et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis
Ellen M. Mowry et al.
ANNALS OF NEUROLOGY (2012)
Regulation of Immune Responses by Prostaglandin E-2
Pawel Kalinski
JOURNAL OF IMMUNOLOGY (2012)
A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosis
Merja Soilu-Hanninen et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2012)
Relationship between 25-OH-D serum level and relapse rate in multiple sclerosis patients before and after vitamin D supplementation
Charles Pierrot-Deseilligny et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2012)
Seasonal Variation in 25-Hydroxyvitamin D Concentrations in the Cardiovascular Health Study
Abigail B. Shoben et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2011)
Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis
Steve Simpson et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2011)
Efficacy of vitamin D3 as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: A Phase II, multicenter, double-blind, randomized, placebo-controlled trial
Joost Smolders et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2011)
Latitudinal prevalence gradient of multiple sclerosis in Latin America
J. Risco et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis
M. S. Stein et al.
NEUROLOGY (2011)
UV-induced immunosuppression and the efficacy of vaccination
Mary Norval et al.
PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES (2011)
The Consequences of UV-Induced Immunosuppression for Human Health
Mary Norval et al.
PHOTOCHEMISTRY AND PHOTOBIOLOGY (2011)
Widespread vitamin D insufficiency: A new challenge for primary prevention, with particular reference to multiple sclerosis
Charles Pierrot-Deseilligny et al.
PRESSE MEDICALE (2011)
Modulation of the immune system by UV radiation: more than just the effects of vitamin D?
Prue H. Hart et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Vitamin D: Evolutionary, Physiological and Health Perspectives
Michael F. Holick
CURRENT DRUG TARGETS (2010)
Ultraviolet Irradiation of Mice Reduces the Competency of Bone Marrow-Derived CD11c+ Cells via an Indomethacin-Inhibitable Pathway
Royce L. X. Ng et al.
JOURNAL OF IMMUNOLOGY (2010)
Serum 25-Hydroxyvitamin D and the Incidence of Acute Viral Respiratory Tract Infections in Healthy Adults
James R. Sabetta et al.
PLOS ONE (2010)
Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: an ecologic meta-regression analysis
T. Hagenau et al.
OSTEOPOROSIS INTERNATIONAL (2009)
Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis
J. Smolders et al.
MULTIPLE SCLEROSIS JOURNAL (2008)
Vitamin D: A candidate for the environmental effect in multiple sclerosis - Observations from Norway
Margitta T. Kampman et al.
NEUROEPIDEMIOLOGY (2008)
1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by inhibiting chemokine synthesis and monocyte trafficking
Laura B. Pedersen et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2007)
Vitamin D deficiency
Michael F. Holick
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors
Alberto Ascherio et al.
ANNALS OF NEUROLOGY (2007)
MSBase:: an international, online registry and platform for collaborative outcomes research in multiple sclerosis
H. Butzkueven et al.
MULTIPLE SCLEROSIS (2006)
Immunoregulation by 1,25-dihydroxyvitamin D3:: Basic concepts
E van Etten et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2005)
Seasonal variation of multiple sclerosis exacerbations in Japan
G Ogawa et al.
NEUROLOGICAL SCIENCES (2004)
Seasonal variations in exacerbations and MRI parameters in relapsing-remitting multiple sclerosis
JA Koziol et al.
NEUROEPIDEMIOLOGY (2004)
Prospective study on the relationship between infections and multiple sclerosis exacerbations
D Buljevac et al.
BRAIN (2002)
An explanation for the seasonality of acute upper respiratory tract viral infections
R Eccles
ACTA OTO-LARYNGOLOGICA (2002)
Epidemiology of varicella zoster virus infection in Canada and the United Kingdom
M Brisson et al.
EPIDEMIOLOGY AND INFECTION (2001)
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis
WI McDonald et al.
ANNALS OF NEUROLOGY (2001)
Seasonal patterns in optic neuritis and multiple sclerosis:: a meta-analysis
YP Jin et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2000)
Share Paper
